Hoffmann Bernhard 4
4 · Ocuphire Pharma, Inc. · Filed Feb 1, 2022
Insider Transaction Report
Form 4
Hoffmann Bernhard
SVP of Corp. Dev.
Transactions
- Award
Employee Stock Option (right to buy)
2022-01-28+42,500→ 42,500 totalExercise: $2.90Exp: 2032-01-27→ Common Stock (42,500 underlying)
Footnotes (1)
- [F1]The option will vest with respect to 10,625 shares on January 28, 2023, and then with respect to 885 shares on the last day of each month from February 2023 through December 2025 and with respect to 900 shares at the end of January 2026.